Depression is a serious global health concern affecting hundreds of millions of people worldwide. It is a highly prevalent and disabling psychiatric disorder that causes significant impairment in daily functioning and quality of life. Its core symptoms of persistent low mood, loss of interest, and other disturbances can severely impair daily functioning and quality of life. This debilitating condition is predicted to become the leading cause of disability worldwide by 2030 (Vieta et al., 2021). While antidepressants are commonly prescribed, this review will argue that Cognitive-Behavioral Therapy (CBT) is the most effective psychological treatment approach for managing depression. In the paper, empirical evidence demonstrating CBT’s efficacy for depression will be presented, and reasons for its superiority over other interventions will be discussed.
According to the study by Apolinário-Hagen et al. (2020), cognitive Behavioral Therapy (CBT) is a highly structured, time-limited form of psychotherapy that focuses on identifying and modifying maladaptive thoughts, attitudes, and behaviors to improve mood, emotions, and functioning. CBT is typically administered in 60-90 minute individual or group therapy sessions weekly over several months. They argue that CBT employs specific techniques and strategies aimed at identifying and altering dysfunctional automatic thoughts, irrational or unhelpful beliefs, and maladaptive behavioral patterns that are associated with various emotional disorders like depression and anxiety (Apolinário-Hagen et al., 2020). Patients learn to monitor their thinking patterns and consciously dispute and replace exaggerated or unrealistic thoughts with more rational, balanced perspectives.
Al-Roubaiy (2020) emphasizes that the most commonly used techniques in CBT for depression are cognitive restructuring and behavioral activation. Cognitive restructuring teaches patients to identify negative automatic thoughts associated with low mood, rigorously evaluate the accuracy and validity of these thoughts, and replace cognitive distortions or exaggerations with more realistic and helpful appraisals. Behavioral activation helps patients increase engagement in pleasant, mastery-oriented activities that provide a sense of pleasure and accomplishment to improve mood and counteract the withdrawal and isolation associated with depression (Al-Roubaiy, 2020). By directly targeting the problematic cognitions and behaviors that maintain depression, CBT can theoretically interrupt the vicious cycle of negative thinking and inactivity to provide symptom relief and improve daily functioning.
Unlike CBT’s focus on altering thoughts and behaviors, some other therapeutic approaches, like psychodynamic therapy, spend more time exploring the unconscious roots of mental health issues. While this can provide insight, it may not lead to the same skill-building and symptom relief as CBT’s active strategies. Similarly, humanistic therapies like Rogerian person-centered therapy utilize non-directive listening, which, while emotionally validating, may not challenge dysfunctional thought patterns. Antidepressant medications also only treat symptoms rather than underlying cognitive and behavioral causes. The direct targeting of problematic thoughts and behaviors makes CBT more immediately actionable for patients. By equipping patients with concrete skills to disrupt cognitive and behavioral maintenance cycles, CBT provides practical tools to counteract depression actively.
Numerous randomized controlled trials have demonstrated the efficacy of CBT for reducing acute symptoms in adults with depression across mild, moderate, and severe presentations (Leopold et al., 2020). For example, a meta-analysis of 15 RCTs found CBT significantly outperformed control conditions in improving depressive symptoms, with moderate to large effect sizes that persisted at 6-month follow-up (Leopold et al., 2020). Another meta-analysis of 24 RCTs confirmed CBT’s superiority over waitlist, placebo, and antidepressant controls for adult depression, with benefits seen across delivery formats like individual, group, telephone, computer, and self-help modalities.
CBT has proven effective for depression across diverse populations and age groups. Randomized controlled trials support its use in children and adolescents, with outcomes comparable or superior to antidepressant medication (Braillon, 2021). CBT reduces symptoms in older adults, either alone or in combination with medication. It also improves depression in patients with significant medical comorbidities, including cancer, cardiovascular disease, chronic pain, and multiple sclerosis. CBT’s transdiagnostic approach can concurrently address medical symptoms like fatigue, disability, and quality of life while treating the underlying depression.
In addition to acute symptom reduction, CBT demonstrates more durable treatment effects than comparison interventions. According to Ng et al. (2023), multiple meta-analyses found that CBT’s superiority over other therapies, including behavioral activation and interpersonal psychotherapy, was most pronounced at 1-year follow-up. The emphasis in CBT on teaching portable skills for independently managing mood likely underlies its maintenance of gains over the long term. By learning and practicing CBT techniques during therapy sessions and as homework, patients gain coping skills to manage their depression even after treatment ends actively. This transfer of CBT skills that patients can apply to real-world situations may account for its superior durability and relapse prevention effects compared to more passive therapies.
Cuijpers et al. (2021) emphasize that numerous meta-analyses of randomized controlled trials have demonstrated CBT’s superiority over other common depression treatments, both pharmacological and psychosocial, in the short and long term. For example, direct comparisons of individual CBT and antidepressant medication show more significant symptom reduction from CBT, with higher rates of remission and lower attrition (Cuijpers et al., 2021). Additional meta-analyses confirm CBT outperforms leading psychosocial options like interpersonal psychotherapy and psychodynamic approaches.
CBT’s highly focused approach, directly targeting the cognitive-behavioral processes that maintain depression, likely explains its advantages over other therapies (Huibers et al., 2021). While antidepressants only address neurochemical imbalances, CBT teaches patients to identify and modify their negative automatic thoughts, maladaptive beliefs, and avoidant/withdrawn behaviors that drive mood disturbances. By learning and practicing portable coping skills during sessions and as homework, patients can actively manage their illness even after treatment ends. This transfer and application of CBT skills to real-world situations may account for its superior durability and relapse prevention effects compared to passive treatments like medication.
Finally, the study by Hrynyschyn & Dockweiler (2021) emphasizes that CBT’s proven efficacy across the full spectrum of depression severities, diverse populations, and flexible delivery formats greatly expands its clinical utility beyond other therapies (Hrynyschyn & Dockweiler, 2021). CBT demonstrates effectiveness in treating mild, moderate, and severe major depressive disorder, allowing clinicians to match treatment intensity to symptom profile. Brief computerized CBT programs also increase access for patients who cannot attend traditional psychotherapy. Remote delivery via the Internet, telephone, and self-help resources provides care options when in-person visits are impractical or unavailable. Unlike medication, which must be taken continually, CBT skills are portable, empowering patients to manage symptoms independently. CBT’s focus on learning skills also makes it compatible with antidepressant medications, group support, psychoeducation, and lifestyle approaches within a comprehensive biopsychosocial care plan tailored to the patient’s needs and treatment preferences.
In conclusion, a robust evidence base supports Cognitive-Behavioral Therapy as an optimal first-line psychological treatment for depression. Controlled trials demonstrate that it works for various types of depression, ages, settings, etc. CBT outperforms other common treatments like medication and therapy for durable symptom improvement because it teaches valuable coping skills. While combined treatment can be beneficial for severe cases, CBT’s ability to directly target problematic thoughts and behaviors makes it a first-line option. Given depression’s global burden, increasing access to CBT through training, technology, and integration into primary care could substantially boost the population’s mental health. CBT empowers patients to manage this disabling condition. While CBT has strong evidence as a frontline intervention, it can also be integrated into a broader biopsychosocial care plan, including medication, education, lifestyle changes, and other modalities tailored to the patient’s needs. CBT provides patients with evidence-based coping skills that can be combined with other treatments to address biological, psychological, and social components underlying this complex disorder.
Al-Roubaiy, N. S. (2020). One cognitive behavior therapy integration pathway: Introducing assimilative integrative rational emotive behavior therapy. The Cognitive Behaviour Therapist, 13. https://doi.org/10.1017/s1754470x20000069
Apolinário-Hagen, J., Drüge, M., & Fritsche, L. (2020). Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: Integrating traditional with digital treatment approaches. Advances in Experimental Medicine and Biology, 291-329. https://doi.org/10.1007/978-981-32-9705-0_17
Braillon, A. (2021). Reader response: Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial. Neurology, 96(8), 406-407. https://doi.org/10.1212/wnl.0000000000011470
Cuijpers, P., Oud, M., Karyotaki, E., Noma, H., Quero, S., Cipriani, A., Arroll, B., & Furukawa, T. A. (2021). Psychologic treatment of depression compared with pharmacotherapy and combined treatment in primary care: A network meta-analysis. The Annals of Family Medicine, 19(3), 262-270. https://doi.org/10.1370/afm.2676
Hrynyschyn, R., & Dockweiler, C. (2021). Effectiveness of smartphone-based cognitive behavioral therapy among patients with major depression: Systematic review of health implications. JMIR mHealth and uHealth, 9(2), e24703. https://doi.org/10.2196/24703
Huibers, M. J., Lorenzo-Luaces, L., Cuijpers, P., & Kazantzis, N. (2021). On the road to personalized psychotherapy: A research agenda based on cognitive behavior therapy for depression. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.607508
Leopold, K., Bauer, M., Bechdolf, A., Correll, C. U., Holtmann, M., Juckel, G., Lambert, M., Meyer, T. D., Pfeiffer, S., Kittel‐Schneider, S., Reif, A., Stamm, T. J., Rottmann‐Wolf, M., Mathiebe, J., Kellmann, E. L., Ritter, P., Krüger‐Özgürdal, S., Karow, A., Sondergeld, L., … Pfennig, A. (2020). Efficacy of cognitive‐behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study. Bipolar Disorders, 22(5), 517-529. https://doi.org/10.1111/bdi.12894
Ng, M. Y., DiVasto, K. A., Gonzalez, N., Cootner, S., Lipsey, M. W., & Weisz, J. R. (2023). How do cognitive behavioral therapy and interpersonal psychotherapy improve youth depression? Applying meta-analytic structural equation modeling to three decades of randomized trials. Psychological Bulletin, 149(9-10), 507-548. https://doi.org/10.1037/bul0000395
Vieta, E., Alonso, J., Pérez-Sola, V., Roca, M., Hernando, T., Sicras-Mainar, A., Sicras-Navarro, A., Herrera, B., & Gabilondo, A. (2021). Epidemiology and costs of depressive disorder in Spain: The EPICO study. European Neuropsychopharmacology, 50, 93-103. https://doi.org/10.1016/j.euroneuro.2021.04.022